Free Trial

Coeptis Therapeutics (COEP) News Today

Coeptis Therapeutics logo
$12.13 +0.63 (+5.44%)
As of 12:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
COEP Stock trading resumes
COEP Stock trading halted, volatility trading pause
Coeptis Therapeutics’ NexGenAI partners with Arketyp Valu
Coeptis launching investment arm
Coeptis Slides After New Round of Financing
Coeptis adds $5.7M to Series A, raises total to $10M
Coeptis Therapeutics regains compliance with Nasdaq listing rules
Coeptis Therapeutics Holdings Inc trading resumes
Coeptis Therapeutics Holdings Inc trading halted, news pending
Coeptis Therapeutics Announces Reverse Stock Split
Coeptis Therapeutics to acquire NexGenAI Affiliates Network
Get Coeptis Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for COEP and its competitors with MarketBeat's FREE daily newsletter.

COEP Media Mentions By Week

COEP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

COEP
News Sentiment

0.00

0.72

Average
Medical
News Sentiment

COEP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

COEP Articles
This Week

1

1

COEP Articles
Average Week

Get Coeptis Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for COEP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:COEP) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners